Publication	Data		Fish	Anatomy
Castro et al., 2020	Fig. 1		hmgcs1vu57/vu57	whole organism axin2 expression decreased amount, abnormal whole organism ccnd1 expression decreased amount, abnormal whole organism lef1 expression decreased amount, abnormal
	Fig. 2		hmgcs1vu57/vu57	ceratobranchial cartilage absent, abnormal ceratohyal cartilage absent, abnormal embryonic viscerocranium morphogenesis disrupted, abnormal Meckel's cartilage absent, abnormal whole organism axin2 expression decreased amount, abnormal whole organism col2a1a expression decreased amount, abnormal whole organism sox10 expression decreased amount, abnormal
Hernandez et al., 2019	Fig. 1		hmgcs1vu57/vu57	nucleate erythrocyte decreased amount, abnormal whole organism hemoglobin decreased amount, abnormal
	Fig. 2		hmgcs1vu57/vu57	intermediate cell mass of mesoderm alas2 expression increased amount, abnormal intermediate cell mass of mesoderm alas2 expression increased distribution, abnormal intermediate cell mass of mesoderm hbbe1.1 expression increased amount, abnormal intermediate cell mass of mesoderm hbbe1.1 expression increased distribution, abnormal
	Fig. 3		hmgcs1vu57/vu57 ,   WT + MO1-hmgcs1	intermediate cell mass of mesoderm gata1a expression decreased amount, abnormal whole organism gata1a expression decreased amount, abnormal
Quintana et al., 2017	Fig. 1		hmgcs1vu57/vu57	basihyal cartilage absent, abnormal ceratobranchial cartilage malformed, abnormal ceratohyal cartilage morphology, abnormal embryonic viscerocranium morphogenesis disrupted, abnormal Meckel's cartilage truncated, abnormal
	Fig. 3		hmgcs1vu57/vu57 ,   hmgcs1vu57/vu57; vu234Tg	ceratobranchial cartilage mRFP expression decreased amount, abnormal ceratohyal cartilage mRFP expression decreased amount, abnormal cranial neural crest neural crest cell differentiation process quality, abnormal Meckel's cartilage mRFP expression decreased amount, abnormal pharyngeal pouch col2a1a expression decreased amount, abnormal
Mathews et al., 2016	Fig. 1		hmgcs1vu57/vu57; vu12Tg	oligodendrocyte MAPK cascade decreased occurrence, abnormal oligodendrocyte TOR signaling decreased occurrence, abnormal spinal cord oligodendrocyte ab1-rps6 labeling decreased amount, abnormal spinal cord oligodendrocyte ab20-mapk labeling decreased amount, abnormal
	Fig. 2		hmgcs1vu57/vu57	hindbrain oligodendrocyte mbpa expression decreased amount, abnormal hindbrain oligodendrocyte plp1a expression decreased amount, abnormal
	Fig. 6		hmgcs1vu57/vu57; vu16Tg	spinal cord central nervous system myelination decreased occurrence, abnormal
Mathews et al., 2014	Fig. 1		hmgcs1vu57/vu57 (AB) ,   hmgcs1vu57/vu57; vu12Tg	brain apoptotic, abnormal heart edematous, abnormal mandibular arch skeleton decreased size, abnormal oligodendrocyte mislocalised dorsally, abnormal spinal cord has fewer parts of type spinal cord oligodendrocyte, abnormal spinal cord oligodendrocyte dorsal to dorsal longitudinal fasciculus, abnormal spinal cord oligodendrocyte mislocalised dorsally, abnormal
	Fig. 2		hmgcs1vu57/vu57 (AB)	central nervous system myelination decreased process quality, abnormal hindbrain oligodendrocyte poorly differentiated, abnormal oligodendrocyte differentiation process quality, abnormal spinal cord oligodendrocyte poorly differentiated, abnormal
	Fig. 4		hmgcs1vu57/vu57 (AB) ,   hmgcs1vu57/vu57; vu12Tg	hindbrain oligodendrocyte poorly differentiated, abnormal oligodendrocyte development process quality, abnormal oligodendrocyte differentiation process quality, abnormal oligodendrocyte mislocalised dorsally, abnormal spinal cord oligodendrocyte far from dorsal longitudinal fasciculus, abnormal
	Fig. 5		hmgcs1vu57/vu57 (AB) ,   hmgcs1vu57/vu57; vu12Tg ,   hmgcs1vu57/vu57; vu16Tg	hindbrain oligodendrocyte poorly differentiated, abnormal oligodendrocyte development process quality, abnormal oligodendrocyte differentiation process quality, abnormal spinal cord oligodendrocyte dorsal to dorsal longitudinal fasciculus, abnormal spinal cord oligodendrocyte mislocalised dorsally, abnormal
	Fig. 7		hmgcs1vu57/vu57 (AB) ,   hmgcs1vu57/vu57; vu12Tg	hindbrain oligodendrocyte poorly differentiated, abnormal oligodendrocyte development process quality, abnormal oligodendrocyte differentiation process quality, abnormal spinal cord oligodendrocyte dorsal to dorsal longitudinal fasciculus, abnormal spinal cord oligodendrocyte mislocalised dorsally, abnormal
	Fig. 8		hmgcs1vu57/vu57; vu16Tg	dorsal longitudinal fasciculus axon ensheathment in central nervous system decreased process quality, abnormal